117 results
8-K
EX-99.1
DMTK
DermTech Inc
18 Apr 24
Dermtech to Explore Strategic Alternatives and Implement Restructuring Plan
4:19pm
tests by government payers (including Medicare) and commercial payers; (5) the ability of patients or healthcare providers to obtain coverage
8-K
EX-99.1
DMTK
DermTech Inc
29 Feb 24
Dermtech Reports Fourth-quarter 2023 Financial Results
4:05pm
for evaluating melanoma, while also lowering healthcare costs and providing a better patient experience. We continue to be inspired by the patient … ; (5) the ability of patients or healthcare providers to obtain coverage of or sufficient reimbursement for DermTech’s products; (6) DermTech’s ability
8-K
EX-99.1
DMTK
DermTech Inc
31 Jan 24
Dermtech Announces Additional Restructuring Actions to Focus on Revenue Growth and Streamline Operations
4:32pm
Medicare) and commercial payers; (5) the ability of patients or healthcare providers to obtain coverage of or sufficient reimbursement for DermTech’s
8-K
EX-99.1
8rth ue7wzrie0kys7
2 Nov 23
Dermtech Reports Third-quarter 2023 Financial Results
4:09pm
8-K
EX-99.1
t67tfju67r26v624
11 Sep 23
Dermtech Appoints Mark Aguillard As Chief Commercial Officer
8:10am
8-K
EX-99.1
4wz4j essidsy
3 Aug 23
Dermtech Reports Second-quarter 2023 Financial Results
4:07pm
8-K
EX-99.1
hntbl2 ds4bjx1vwdqr
28 Jun 23
Dermtech Announces Restructuring to Prioritize Growth Opportunities and Streamline Operations
4:35pm
DEFA14A
32as3btwv hnsu
9 May 23
Additional proxy soliciting materials
4:03pm
8-K
EX-99.1
xg19iirz8i7zwcyj0
9 May 23
Dermtech Appoints Bret Christensen As New President and Ceo
8:30am
8-K
EX-99.1
2q06 1gpha6zr0qm49v
4 May 23
Dermtech Reports First-quarter 2023 Financial Results
4:06pm
8-K
EX-99.1
b4wd83xhj3j bn
3 Nov 22
Dermtech Reports Third-quarter 2022 Financial Results
4:06pm
424B5
uiu75cwfkx3f
17 Aug 22
Prospectus supplement for primary offering
4:23pm